Jin Sheng Selected Research

Cognitive Dysfunction

1/2013

Uridine prodrug improves memory in Tg2576 and TAPP mice and reduces pathological factors associated with Alzheimer's disease in related models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin Sheng Research Topics

Disease

16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2014
12	Neoplasms (Cancer) 01/2022 - 07/2009
2	Myocardial Infarction 05/2019 - 05/2015
2	Nasopharyngeal Carcinoma 01/2018 - 10/2016
2	Necrosis 08/2016 - 07/2009
2	Huntington Disease (Huntington's Disease) 01/2013 - 12/2006
1	Hyperplasia 04/2022
1	Pathologic Constriction (Stenosis) 04/2022
1	Thrombosis (Thrombus) 04/2022
1	Arteriosclerosis 04/2022
1	Disease Progression 01/2021
1	Shock 05/2019
1	Adenocarcinoma of Lung 09/2017
1	Death (Near-Death Experience) 01/2017
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Nausea 01/2017
1	Vomiting 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2016
1	Exanthema (Rash) 04/2016
1	Diarrhea 04/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2016
1	Infarction (Infarctions) 05/2015
1	Stroke (Strokes) 01/2013
1	Amyloid Plaque 01/2013
1	Cognitive Dysfunction 01/2013
1	Parkinson Disease (Parkinson's Disease) 01/2013
1	Alzheimer Disease (Alzheimer's Disease) 01/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Osteosarcoma (Osteogenic Sarcoma) 07/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2006

Drug/Important Bio-Agent (IBA)

7	ErbB Receptors (EGF Receptor)IBA 08/2016 - 01/2014
4	Tyrosine Kinase InhibitorsIBA 08/2016 - 01/2014
3	Gefitinib (Iressa)FDA Link 01/2017 - 04/2016
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 10/2016
2	Proteins (Proteins, Gene)FDA Link 10/2016 - 03/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2016 - 04/2016
2	Cytotoxins (Cytolysins)IBA 08/2015 - 01/2015
2	Angiogenesis InhibitorsIBA 08/2015 - 01/2015
2	ProdrugsIBA 01/2013 - 12/2006
2	UridineIBA 01/2013 - 12/2006
2	uridine triacetateIBA 01/2013 - 12/2006
1	MetalsIBA 04/2022
1	CholesterolIBA 04/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	atezolizumabIBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 10/2019
1	pembrolizumabIBA 09/2017
1	Immune Checkpoint InhibitorsIBA 09/2017
1	Neurokinin-1 Receptor AntagonistsIBA 01/2017
1	CytokinesIBA 01/2017
1	Messenger RNA (mRNA)IBA 10/2016
1	Cisplatin (Platino)FDA LinkGeneric 10/2016
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 10/2016
1	Thymidylate SynthaseIBA 10/2016
1	Indicators and Reagents (Reagents)IBA 08/2016
1	vandetanib (ZD6474)IBA 08/2016
1	AfatinibIBA 04/2016
1	Transaminases (Aminotransferases)IBA 04/2016
1	AlbuminsIBA 03/2016
1	GlobulinsIBA 03/2016
1	NivolumabIBA 01/2016
1	Monoclonal AntibodiesIBA 08/2015
1	Taxoids (Taxanes)IBA 08/2015
1	Biomarkers (Surrogate Marker)IBA 08/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013
1	Neuroprotective AgentsIBA 01/2013
1	Mitochondrial DNA (mtDNA)IBA 01/2013
1	tetra-4-amidinophenoxypropane (TAPP)IBA 01/2013
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2013
1	CeramidesIBA 01/2013
1	Amyloid (Amyloid Fibrils)IBA 01/2013
1	Capsules (Microcapsules)IBA 07/2009
1	Coloring Agents (Dyes)IBA 07/2009
1	3-nitropropionic acidIBA 12/2006

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2017 - 07/2009
6	Therapeutics 01/2022 - 01/2015
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2022
1	Immunotherapy 12/2020
1	Percutaneous Coronary Intervention 05/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Neoadjuvant Therapy 01/2016
1	Ligation 05/2015
1	Thoracotomy 05/2015
1	Limb Salvage 07/2009